Coppell, TX, United States of America

Ming Zhou

USPTO Granted Patents = 32 

 

 

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 130(Granted Patents)


Location History:

  • Arlington, TX (US) (2007)
  • Dallas, TX (US) (2013 - 2014)
  • Coppell, TX (US) (2010 - 2021)
  • Draper, UT (US) (2020 - 2021)
  • Cambridge, MA (US) (2020 - 2023)
  • Buffalo Grove, IL (US) (2022 - 2024)

Company Filing History:


Years Active: 2007-2025

Loading Chart...
Loading Chart...
Loading Chart...
32 patents (USPTO):

Title: Innovations of Ming Zhou in the Field of Biomedicine

Introduction: Ming Zhou, based in Coppell, TX, is an accomplished inventor with an impressive portfolio of 25 patents. His work primarily revolves around the development of biopharmaceutical solutions targeting various medical conditions. His latest innovations continue to make significant contributions to the fields of molecular biology and therapeutic treatments.

Latest Patents: Among Ming Zhou's notable recent patents are the peptide oligonucleotide conjugates. These patents detail the composition of oligonucleotides, peptides, and peptide-oligonucleotide conjugates. The described methods focus on treating muscle diseases, as well as viral and bacterial infections, through the administration of these innovative compounds. This cutting-edge research aims to provide new therapeutic strategies for patients in need of effective medical interventions.

Career Highlights: Throughout his career, Ming Zhou has made substantial advances in biomedicine, holding key positions in reputable companies. His experience includes significant contributions at Sarepta Therapeutics, Inc. and Joyant Pharmaceuticals, Inc., where he has played an instrumental role in advancing therapeutic technologies. His work has not only led to numerous patents but has also positioned him as a leading figure in his field.

Collaborations: Collaboration is a cornerstone of scientific advancement, and Ming Zhou has partnered with notable colleagues such as Gunnar James Hanson and Qi Wei. Together, they have worked on innovative projects that leverage their collective expertise, enhancing the potential for successful biopharmaceutical developments.

Conclusion: Ming Zhou’s contributions to the realm of biomedicine through his 25 patents and collaborative efforts mark him as a distinguished inventor. His latest innovations in peptide oligonucleotide conjugates reflect his commitment to advancing medical therapies and improving patient outcomes. As he continues to drive innovation in his field, Ming Zhou stands as a testament to the power of inventive thinking and scientific collaboration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…